Contribution of the dopaminergic image in patients with parkinsonism. Perspective from the Neurology consultation

Robertson, 2017, Proposed biochemistry of Parkinson's and Alzheimer's diseases, Med Hypotheses, 109, 131, 10.1016/j.mehy.2017.08.013 Nussbaum, 2003, Alzheimer's disease and Parkinson's disease, N Engl J Med, 348, 1356, 10.1056/NEJM2003ra020003 Chang, 2017, International Parkinson's Disease Genomics Consortium. A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci, Nat Genet, 4, 1511, 10.1038/ng.3955 Braak, 2009, Neuroanatomy and pathology of sporadic Parkinson's disease, Adv Anat Embryol Cell Biol, 201, 1 Braak, 2017, Neuropathological staging of brain pathology in sporadic Parkinson's disease: Separating the wheat from the chaff, J Parkinsons Dis, 7, S73 Schrag, 2017, Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study, Lancet Neurol, 16, 66, 10.1016/S1474-4422(16)30328-3 Hansson, 2017, A biomarker for differential diagnosis of parkinsonian disorder, Neurology, 88, 930, 10.1212/WNL.0000000000003680 Pietracupa, 2017, Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review, Neurol Sci, 38, 2095, 10.1007/s10072-017-3099-y Heim, 2017, Magnetic resonance imaging for the diagnosis of Parkinson's disease, J Neural Transm (Vienna), 124, 915, 10.1007/s00702-017-1717-8 Apostolova, 2017, Utility of follow-up dopamine transporter SPECT with 123I-FP-CIT in the diagnostic workup of patients with clinically uncertain parkinsonian syndrome, Clin Nucl Med, 42, 589, 10.1097/RLU.0000000000001696 Firbank, 2017, Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study, J Neurol Neurosurg Psychiatry, 88, 310, 10.1136/jnnp-2016-313918 Louis, 2009, The essential tremors: a family of neurodegenerative disorders?, Arch Neurol, 66, 1202, 10.1001/archneurol.2009.217 Levin, 2017, Nonmotor symptoms in vascular and other secondary parkinsonism, Int Rev Neurobiol, 134, 1303, 10.1016/bs.irn.2017.05.016 Tripathi, 2014, Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT, Neuroradiol J, 27, 13, 10.15274/NRJ-2014-10002 Uyama, 2017, The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and 123I-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes, Nucl Med Commun, 38, 487, 10.1097/MNM.0000000000000674 Tsartsalis, 2017, A single-scan protocol for absolute D2/3 receptor quantification with [123I]IBZM SPECT, Neuroimage, 147, 461, 10.1016/j.neuroimage.2016.12.050 Darcourt, 2010, EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2, Eur J Nucl Med Mol Imaging, 37, 443, 10.1007/s00259-009-1267-x European Medicines Agency, 2017